Role of the interleukin-6 -174 G>C gene polymorphism in retinal artery occlusion

Stroke

Volumn 36, Issue 2, 2005, Pages 249-252

  Weger, Martin ^a   Steinbrugger, Iris ^a   Haas, Anton ^a   März, Winfried ^a   El Shabrawi, Yosuf ^a   Weger, Wolfgang ^a   Schmut, Otto ^a   Renner, Wilfried ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Atherosclerosis; Genetics; Interleukin 6; Ophthalmology; Retinal artery occlusion; Risk factors

Indexed keywords

CYTOKINE; INTERLEUKIN 6;

ADULT; AGED; ALLELE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FUNCTION; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RETINA ARTERY OCCLUSION; RISK ASSESSMENT; RISK FACTOR;

AGED; ALLELES; BLOOD PRESSURE; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; FEMALE; GENOTYPE; HOMOZYGOTE; HUMANS; INTERLEUKIN-6; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, STATISTICAL; ODDS RATIO; POLYMORPHISM, GENETIC; RETINAL ARTERY OCCLUSION; RETROSPECTIVE STUDIES;

EID: 12844273455     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000151329.84830.37     Document Type: Article

References (42)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
2. Young JL, Libby P, Schönbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost. 2002;88:554-567.
3. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol. 1990;8:253-278.
4. Sukovich DA, Kauser K, Shirley FD, Del Vecchio V, Halks-Miller M, Rubanyi GM. Expression of interleukin-6 in atherosclerotic lesions of male ApoE- knockout mice: inhibition by 17beta-estradiol. Arterioscler Thromb Vasc Biol. 1998;18:1498-1505.
5. Ikeda U, Ikeda M, Seino Y, Takahashi M, Kano S, Shimada K. Interleukin 6 gene transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits. Atherosclerosis. 1992;92:213-218.
6. Seino Y, Ikeda U, Ikeda M, Yamamoto K, Misawa Y, Hasegawa T, Kano S, Shimada K. Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine. 1994;6:87-91.
7. Huber SA, Sakkinen P, Conze D, Hardin N, Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 1999;19:2364-2367.
8. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996;94:874-877.
9. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH, Plasma concentrations of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101:1767-1772.
10. Luc G, Bard JM, Juhan-Vague I, Ferneres J, Evans A, Amouyel P, Arveiler D, Fruchart JC, Ducimetiere P; PRIME Study Group. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease. Aneriosler Thromb Vasc Biol. 2003;23:1255-1261.
11. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease. JAMA. 2002;288:980-987.
12. Cesari M, Penninx B, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M. Inflammatory markers and onset of cardiovascular events. Results from the Health ABC Study. Circulation. 2003;108:2317-2322.
13. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin invest. 1998;102:1369-1376.
14. Hoffmann SC, Stanley EM, Darrin Cox E, Craighead N, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/ CD28-stimulated peripheral blood lymphocytes. Transplantation. 2001;72:1444-1450.
15. Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology. 2001;40:656-661.
16. Burzotta F, Iacoviello L, Di Castelnuovo A, Glieca F, Luciani N, Zamparelli R, Schiavello R, Donati MB, Maseri A, Possati G, Andreotti F. Relation of the -174G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol. 2001;88:1125-1128.
17. Pola R, Flex A, Gaetani E, Flore R, Serricchio M, Pola P. Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with a history of ischemic stroke. Stroke. 2003;34:881-885.
18. Georges JL, Loukaci V, Poirier O, Evans A, Luc G, Arveiler D, Ruidavets JB, Cambien F, Tiret L. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. J Mol Med. 200l;79:300-305.
19. Rauramaa R, Väisänen SB, Luong LA, Schmidt-Trücksäss A, Penttilä IM, Bouchard C, Töyry J, Humphries SE. Stromeolysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol. 2000;20:2657-2662.
20. Jerrard-Dunne P, Sitzer M, Risley P, Steckel DA, Buehler A, von Kegler S, Markus HS. Interleukin-6 promoter polymorphism modulates the effects of heavy alcohol consumption on early carotid artery atherosclerosis. Stroke. 2003;34:402-407.
21. Basso F, Lowe GD, Rumley A, McMahon AD, Humphries SE. Interleukin-6 -174G>C polymorphism and the risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol. 2002;22:599-604.
22. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ. The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Ear Heart J. 2001;22:2243-2252.
23. Chapman CM, Beilby JP, Humphries SE, Palmer LJ, Thompson PL, Hung J. Association of an allelic variant of interleukin-6 with subclinical carotid atherosclerosis in an Australian community population. Eur Heart J. 2003;24:1494-1499.
24. Revilla M, Obach V, Cerveta A, Davalos A, Castillo J, Chamorro A. A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction. Neurosci Lett. 2002;324:29-32.
25. Rundek T, Elkind MS, Pittman J, Boden-Albala B, Martin S, Humphries SE, Juo SH, Sacco RL. Carotid intima-media thickness is associated with allelic variants of stromeolysin-1, interleukin-6, and hepatic lipase genes. The Northern Manhattan Prospective Cohort Study. Stroke. 2002;33:1420-1423.
26. Blice JB, Brown GC. Retinal vascular occlusive disease. In: Spaide RF, ed. Diseases of the Retina and Vitreous. Philadelphia, Pa: WB Saunders Co; 1999:109-127.
27. Brown GC. Retinal artery occlusive diseases. In: Guyer DR, Yanuzzi LA, Chang S, Shields YA, Green WR, eds. Retina-Vitreous-Macula. Philadelphia, Pa: WB Saunders Co; 1999:271-285.
28. Cahill M, Karabatzaki M, Meleady R, Refsum H, Ueland P, Shields D, Mooney D, Graham I. Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol. 2000;84:154-157.
29. Weger M, Stanger O, Deutschmann H, Leitner FJ, Renner W, Schmut O, Semmelrock J, Haas A. The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion. Am J Ophthalmol. 2002;134:57-61.
30. Dupont WD, Plummer WD. PS power and sample size program available for free on the Internet. Control Clin Trials. 1997;18:274.
31. Nauck M, Winkelmann BR, Hoffmann MM, Böhm BO, Wieland H, März W. The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J Mol Med. 2002;80:507-513.
32. Reich K, Westphal G, König IR, Mössner R, Schupp P, Gutgesell C, Hallier E, Ziegler A, Neumann C. Cytokine gene polymorphisms in atopic dermatitis. Br J Dermatol. 2003;148:1237-1241.
33. Bown MJ, Horsburgh T, Nicholson ML, Bell PR, Sayers RD. Cytokine gene polymorphisms and the inflammatory response to abdominal aortic aneurysm repair. Br J Surg. 2003;90:1085-1092.
34. Ortlepp JR, Metrikat J, Vesper K, Mevissen V, Schmitz F, Albrecht M, Maya-Pelzer P, Hanrath P, Weber C, Zerres K, Hoffmann R. The interleukin-6 promoter polymorphism is associated with elevated leukocyte, lymphocyte, monocyte counts and reduced physical fitness in young healthy smokers. J Mol Med. 2003;81:578-584.
35. Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, van Hinsbergh V, Sozzani S, Bussolino F, Poli V, Ciliberto G, Mantovani A. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 1997;6:315-325.
36. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 1994;75:181-189.
37. Ikeda U, Ikeda M, Seino Y, Takahashi M, Kasahara T, Kano S, Shimada K. Expression of intercellular adhesion molecule-1 on rat vascular smooth muscle cells by pro-inflammatory cytokines. Atherosclerosis. 1993;104:61-68.
38. Dalmon J, Laurent M, Courtois G. The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element. Mol Cell Biol. 1993;13:1183-1193.
39. Stouthard JM, Levi M, Hack CE, Veenhof CH, Romijn HA, Sauerwein HP, van der Poll T. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost. 1996;76:738-742.
40. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, Lowe GD, Humphries SE. Interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are strong predictors of plasma interleukin-6 after coronary artery bypass surgery. Arteriosler Thromb Vasc Biol. 2001;21:1458-1463.
41. Jones KG, Brull DJ, Brown LC, Sian M, Greenhalgh RM, Humphries SE, Powell JT. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation. 2001;103:2260-2265.
42. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000;275:18138-18144.